Limitations of Right Heart Catheterization in the Diagnosis and Risk Stratification of Patients with Pulmonary Hypertension: Insights from the CHAMPION Trial

Use of a Wireless Implantable Hemodynamic Monitor Leads to Reductions in Heart Failure Hospitalizations Among WHO Group II Pulmonary Hypertension Patients A. Raina ,1 R.C. Bourge,2 W. Abraham,3 P.B. Adamson,4 J. Bauman,5 J. Yadav,5 R.L. Benza.1 1Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, PA; 2Division of Cardiology, University of Alabama at Birmingham, Birmingham, AL; 3Division of Cardiology, Ohio State University, Columbus, OH; 4The Heart Failure Institute, Oklahoma Heart Hospital, Oklahoma City, OK; 5Cardiomems, Inc, Atlanta, GA.